We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesBioqual Inc

Bioqual Inc

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
31.0 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
100
Market Cap
29.52M
P/E
15.87

Momentum Score

…

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology and cytotoxicity testing, viral load testing, and tailored assay development services; and Biocontainment, imaging services, and animal model development; and IND-enabling services, such as toxicology studies, pharmacokinetic profiling, GLP services, and regulatory documentation services. Bioqual, Inc. was incorporated in 1981 and is based in Rockville, Maryland.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
31.00
Low
31.00
High
52 Week Price Range
32.50
Low
40.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
31.00
Dividend Yield
-
Revenue TTM
42.35M
Revenue Per Share
47.35
Gross Profit TTM
8.07M
Debt / Equity
0.46
ROE
-3.47%
Net Debt
-1.31M
ROCE
-3.89%
Diluted EPS TTM
2.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Income before tax -1.29M 0.48M - - -
Net income -1.05M 0.48M - - -
Gross profit -1.90M 7.43M - - -
Ebit -1.90M 0.48M 1.10M 6.53M 8.56M
Ebitda 0.51M 3.03M - - -
Depreciation and amortization 2.41M 2.56M - - -
Operating income -1.90M -0.02M - - -
Other operating expenses 50.76M 58.61M - - -
Interest expense - - - - 0.00M
Income tax expense -0.24M -0.01M 0.30M 1.32M 2.29M
Total revenue 48.87M 58.59M - - -
Total operating expenses 6.32M 7.45M - - -
Cost of revenue 50.76M 51.16M - - -
Total other income expense net 0.61M 0.50M - - -
Net income applicable to common shares - - 0.84M 5.26M 6.33M
Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Total assets 57.12M 56.59M - - -
Other current assets 0.29M 1.28M - - -
Total liab 20.96M 18.94M - - -
Total stockholder equity 36.15M 37.65M - - -
Other current liab 1.79M 2.27M 0.96M 1.17M 0.96M
Common stock 0.02M 0.02M 0.02M 0.02M 0.02M
Retained earnings 29.81M 31.31M 31.27M 31.33M 27.19M
Other liab - - 0.24M 0.25M 0.06M
Good will 1.03M 1.03M - - -
Other assets - - - - 0.11M
Cash 17.85M 15.59M - - -
Total current liabilities 8.42M 7.69M 8.30M 9.77M 8.52M
Current deferred revenue 0.74M 0.45M - - -
Net debt -1.31M -12.01M - - -
Short term debt 3.99M 3.59M - - -
Short long term debt total 16.54M 3.59M - - -
Other stockholder equity 6.32M 6.32M - - -
Property plant equipment - - 30.35M 30.59M 22.96M
Total current assets 31.31M 30.87M 29.94M 31.73M 29.32M
Net tangible assets - - 36.59M 36.64M 32.50M
Net receivables 13.16M 14.00M 20.64M 26.76M 20.11M
Accounts payable 1.90M 1.38M 1.59M 3.29M 2.11M
Non current assets total 25.81M 25.71M - - -
Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Change to liabilities - - -1.90M 1.47M -0.32M
Total cashflows from investing activities -0.24M -0.60M -2.24M -4.73M -3.69M
Total cash from financing activities -0.45M -0.45M -0.89M -1.12M -0.98M
Change to operating activities - - -2.65M -8.02M -2.52M
Net income -1.05M 0.48M 0.84M 5.26M 6.33M
Change in cash 2.26M 8.31M 5.10M -5.54M -2.54M
Begin period cash flow 15.59M 7.28M - - -
End period cash flow 17.85M 15.59M - - -
Total cash from operating activities 2.94M 9.36M 8.23M 0.31M 2.14M
Depreciation - 2.56M 5.83M 8.19M 4.45M
Other cashflows from investing activities - - - 0.15M 0.71M
Dividends paid 0.45M 0.45M -0.89M -1.12M -0.98M
Change to account receivables 0.69M 6.80M 6.12M -6.66M -5.66M
Other cashflows from financing activities - -0.60M - - -
Change to netincome - - -0.01M 0.15M -0.41M
Capital expenditures 0.24M 0.60M 2.24M 4.89M 4.40M
Change in working capital -3.52M 2.85M - - -
Other non cash items 7.51M 3.73M - - -
Free cash flow 2.71M 8.76M - - -

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BIOQ
Bioqual Inc		 -
-%		 31.00 15.87 - 0.70 1.00 0.04 0.24
TMO
Thermo Fisher Scientific Inc		 -15.12
2.11%		 702.59 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 -1.34
0.57%		 233.97 29.09 28.01 5.67 3.20 6.00 19.09
WUXIF
WuXi AppTec Co. Ltd		 -
-%		 24.91 22.29 17.95 1.53 5.98 8.39 14.30
WUXAY
WuXi AppTec Co. Ltd		 -0.17
0.68%		 24.93 23.28 18.73 1.51 6.24 8.39 14.30

Profile*

Bioqual Inc

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology and cytotoxicity testing, viral load testing, and tailored assay development services; and Biocontainment, imaging services, and animal model development; and IND-enabling services, such as toxicology studies, pharmacokinetic profiling, GLP services, and regulatory documentation services. Bioqual, Inc. was incorporated in 1981 and is based in Rockville, Maryland.

9620 Medical Center Drive, Rockville, MD, United States, 20850

240 404 7654

https://www.bioqual.com

Name Title Year Born
Dr. Marisa St. Claire DVM VP - Primate Biology and Medicine 1965
Dr. Mark G. Lewis Ph.D. Chairman, CEO & Pres 1955
Mr. Charles C. Kirk Jr., CPA Chief Financial Officer NA
Mitch Franklin Chief Operating Officer NA
Ms. Hanne Andersen-Elyard Ph.D. Initial Chief Scientific Officer NA
Nancy A. Madden VP of Admin. Operations & Biosafety Officer NA
Dr. J. Thomas August M.D. Consultant & Scientific Adviser 1928
Dr. Mark G. Lewis Ph.D. Chairman of the Board, CEO & President 1955
Ms. Hanne Andersen-Elyard Ph.D. Chief Scientific Officer NA
Dr. Hanne Andersen-Elyard Ph.D. Chief Scientific Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…